Dissecting The Potential Role Of Prevnar As An Anti-Myeloma Vaccine

被引：1
|
作者：
Noonan, Kimberly
Rudraraju, Lakshmi
Ferguson, Anna
Sidorski, Amy
Casildo, Andrea
Griffin, Ervin
Lee, Susan
Ghosh, Nilanjan
Matsui, William
Huff, Carol
Borrello, Ivan M.
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.1980.1980
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1980
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Arterial thromboembolism in multiple myeloma in the context of modern anti-myeloma therapy
    Rajshekhar Chakraborty
    Lisa Rybicki
    Jason Valent
    Alex V. Mejia Garcia
    Beth M. Faiman
    Jack Khouri
    Christy J. Samaras
    Faiz Anwer
    Alok A. Khorana
    Blood Cancer Journal, 11
  • [22] Arterial thromboembolism in multiple myeloma in the context of modern anti-myeloma therapy
    Chakraborty, Rajshekhar
    Rybicki, Lisa
    Valent, Jason
    Garcia, Alex V. Mejia
    Faiman, Beth M.
    Khouri, Jack
    Samaras, Christy J.
    Anwer, Faiz
    Khorana, Alok A.
    BLOOD CANCER JOURNAL, 2021, 11 (06)
  • [23] The Role of BAX/BAK-Mediated Apoptosis for the Cytotoxic Action of Anti-Myeloma Agents
    Yao, Yuan
    Gong, Jia-Nan
    Segal, David
    Riffkin, Chris D.
    van Delft, Mark F.
    Roberts, Andrew W.
    Huang, David C. S.
    BLOOD, 2016, 128 (22)
  • [24] Avicins: A novel class of anti-myeloma agents.
    Mitsiades, N
    McMullan, CJ
    Poulabi, V
    Negri, J
    Geer, DC
    Haridas, V
    Munshi, NC
    Gutterman, J
    Anderson, KC
    Mitsiades, CS
    BLOOD, 2004, 104 (11) : 929A - 929A
  • [25] CHARACTERIZATION OF A PERK KINASE INHIBITOR WITH ANTI-MYELOMA ACTIVITY
    Bagratuni, T.
    Kastritis, E.
    Mavrianou, N.
    Liacos, C.
    Terpos, E.
    Dimopoulos, M.
    HAEMATOLOGICA, 2016, 101 : 512 - 512
  • [26] Venetoclax: the first anti-myeloma agent with a reliable biomarker
    Jelinek, Tomas
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 (06) : 1003 - 1005
  • [27] Emerging of valproic acid as an anti-myeloma agent.
    Kitazoe, Kenichi
    Abe, Masahiro
    Choraku, Masahito
    Kagawa, Kumiko
    Asano, Jin
    Takeuchi, Kyoko
    Hiasa, Masahiro
    Hashimoto, Toshihiro
    Ozaki, Shuji
    Oda, Asuka
    Amou, Hiroe
    Matsumoto, Toshio
    BLOOD, 2006, 108 (11) : 993A - 993A
  • [28] Characterization of a PERK Kinase Inhibitor with Anti-Myeloma Activity
    Bagratuni, Tina
    Patseas, Dimitrios
    Mavrianou-Koutsoukou, Nefeli
    Liacos, Christine Ivy
    Sklirou, Aimilia D.
    Rousakis, Pantelis
    Gavriatopoulou, Maria
    Terpos, Evangelos
    Tsitsilonis, Ourania E.
    Trougakos, Ioannis P.
    Kastritis, Efstathios
    Dimopoulos, Meletios A.
    CANCERS, 2020, 12 (10) : 1 - 20
  • [29] Myeloma bone disease: pathogenesis and management in the era of new anti-myeloma agents
    Jumpei Teramachi
    Hirokazu Miki
    Shingen Nakamura
    Masahiro Hiasa
    Takeshi Harada
    Masahiro Abe
    Journal of Bone and Mineral Metabolism, 2023, 41 : 388 - 403
  • [30] Characterization of a PERK Kinase Inhibitor with Anti-Myeloma Activity
    Bagratuni, Tina
    Mavrianou, Nefeli
    Kastritis, Efstathios
    Liakos, Christine
    Terpos, Evangelos
    Dimopoulos, Meletios A.
    BLOOD, 2015, 126 (23)
12345